Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.
BACKGROUND: Tuberculosis vaccine trials using disease as the primary endpoint are large, time consuming, and expensive.